The Rheumatoid Arthritis (RA) therapeutics market is experiencing strong expansion as autoimmune disorders continue to rise globally and innovative biologics reshape treatment pathways. Rheumatoid arthritis is a chronic inflammatory disease that requires long-term therapy, driving continuous demand for advanced drugs and disease-modifying therapies. The market is evolving rapidly due to...